Ten-Year Counterdrug Technology Plan and Development Roadmap

Implementation

The process for implementing this plan is envisioned as an evolutionary, cooperative undertaking. This plan is offered as a forecast of technological needs and resolutions and is not intended, in any way, to intrude upon or monitor the operational planning and work of the law enforcement agencies. Our starting point in implementing this plan begins with the reported drug control R&D funding shown in Table 4 for each agency. [1]

Table 4: Federal Drug Control Spending by R&D Function, FY 97-99 [1]

Agency	FY 97 Actual ($M)	FY 98 Enacted ($M)	FY 99 Request ($M)
Department of Agriculture (ARS)	4.712	4.709	4.709
Department of Education	0.990	0.711	0.545
U.S. Forest Service	0.115	0.115	0.115
Department of Defense	34.073	24.794	22.458
National Institutes of Health	525.595	554.590	605.799
Bureau of Indian Affairs	1.510	1.854	1.863
The Federal Judiciary	3.184	3.465	3.713
Department of Veterans Affairs	4.400	4.570	4.730
Drug Enforcement Administration	2.911	4.299	3.906
Federal Bureau of Investigation	28.077	28.719	29.569
Immigration and Naturalization Service	0.499	0.520	0.538
Interagency Crime and Drug Enforcement	0.390	0.390	0.390
Office of Justice Programs	11.470	23.526	21.106
Office of National Drug Control Policy	18.000	17.000	17.000
High Intensity Drug Trafficking Areas	0.400	0	0
Special Forfeiture Fund	9.230	0	0
U.S. Coast Guard	0.470	0.938	0.736
Federal Aviation Administration	0.955	1.024	1.075
Nat'l Highway Traffic Safety Adminstration	0.240	0.250	0.300
U.S. Customs Service	5.000	5.000	3.500
TOTAL	652.221	676.474	722.052

The IAWG-T panel leaders listed in Table 5 were assigned from the Science and Technology Committee to lead the preparation of this plan. As progress on implementation occurs, the ONDCP management information system for assessing the performance of the National Drug Control Strategy and agency comparable systems will be used to acquire data on impact targets for each NDCS objective with corresponding performance measures and outcomes. This plan will be modified as necessary to describe and quantify the impact of adopting the optimum set of technologies on impact targets.

Table 5. Technology Panel Leaders

PANEL	NAME	AGENCY
Wide Area Surveillance	Mr. Lennard Wolfson	Department of Defense
Non-Intrusive Inspection	Mr. Raymond Mintz	U.S. Customs Service
Tactical Technologies	Mr. Anthony Bocchichio	Drug Enforcement Administration
Demand Reduction	Dr. Frank Vocci	National Institute on Drug Abuse

The plan recognizes the need for periodic re-evaluation and modification in order to ensure that technological innovations are responsive to the realities of current drug trends and patterns. Over the next year, a clear connection will be made between this plan, the Government Performance and Results Act-based ONDCP FY 1997-2002 Strategic Plan, the ONDCP FY 1999 Annual Performance Plan, and individual agency plans to support a consolidated federal drug control budget. With the 1998 National Drug Control Strategy and the ONDCP Strategic Plan and the ONDCP Annual Performance Plan, the framework for measuring progress in achieving the five goals of the Strategy will be provided. The following actions will be taken to assure that adequate data are available for measuring program performance as these plans come into place:

1. An interagency working group for technology (IAWG-T) will be formed as a working group of the Science and Technology Committee. The IAWG-T (with the assistance of ONDCP components for Strategy, Supply Reduction and Demand Reduction,) will meet quarterly to perform the following functions:

• a schematic will be developed showing each of the 21 agencies involved in the Science and Technology Committee with the respective programs falling under each of them and links between the programs, the Strategy goals, the Development Roadmap and the desired outcomes,
• specific technology-related performance targets will be established by the IAWG-T for each agency technology initiative shown on the schematic,
• a correlation will be made between the technology development / system procurements and each agency's performance measures, impact targets and outcome,
• acquisition plans will be coupled with development efforts with specific agencies identified for each system procurement,
• the anticipated operational impact for each technology development will be quantified,
• a technology roadmap will be developed for demand reduction technology,
• agency specific resource requirements for technology will be estimated on a five-year scale as provided in the President's budget request for each year,
• priorities, or priority categories, will be assigned to ensure that funding is allocated only to technology development efforts of greatest importance to drug control agencies,
• for each panel of technologies, meaningful national goals will be developed with affected agencies to compare, on a case-by-case basis, existing deployed systems and proposed, new technology products to address current operational limitations and shortcomings with anticipated performance and characteristics of future products, and
• inputs will be provided to ONDCP for the development of annual budget guidance that will be used by ONDCP to certify agency drug control budgets.

2. CTAC will work closely with the affected agencies in providing coordination and oversight to the Science and Technology Committee and IAWG-T on some 85 counterdrug research and development programs. CTAC will serve as the central organization for test and evaluation of advanced counterdrug technology prototypes. CTAC also will identify technologies appropriate for transfer to state and local law enforcement organizations. In support of the entire community, CTAC will:

• conduct three regional workshops and one major technology symposium each year,
• working with the appropriate user agencies develop, test and field five technology prototypes within the next five years, and
• develop an improved framework to evaluate new systems being acquired by the federal, state and local agencies and measure their utility to stakeholders.

In the short term, CTAC will track output measures of agency technology programs by activity: number of projects sponsored, number of deployed systems evolving from agency programs, and number of systems evolving from CTAC sponsored projects. In the longer term, CTAC will work closely with relevant agencies to perform qualitative assessments to measure contributions of each project to the overall Strategy goals and objectives. These assessments will also serve to evaluate and improve the measures themselves over time. As the ONDCP reporting system becomes a reality, the agencies may be able to employ more sophisticated assessments and measures to measure process oriented linkages (decrease by x%) as well as end state outcomes (inspect x% of the containers entering port y). For example, implications of the recently announced President's technology initiatives, such as the use of the National Research Laboratory computers, also should be included in the planning process.

Annual updates to this plan will be prepared by the IAWG-T under CTAC leadership. The IAWG-T review process will evaluate whether the plan is meeting the national priorities, impact targets, performance measures, and goals set forth in the National Drug Control Strategy and Performance Measures of Effectiveness System. CTAC will include this plan in its FY 98 technology transfer pilot program to State and local organizations and technical symposia with academic institutions and industry to increase an awareness of progress in technology development in the federal sector.

Previous

Contents

Next